908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call Transcript April 30, 2024 908 Devices Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.37. 908 Devices Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome […]
We caught up with Kevin Knopp, CEO and co-founder of 908 Devices, to discuss the main obstacles in cell and gene therapy manufacturing and how the company's recent partnership with Terumo Blood and Cell Technologies is tackling these challenges.
Operator: Hello and welcome to today s 908 Devices Third Quarter 2023 Financial Results Conference Call. My name is Jordan and I ll be coordinating your call today.